The second wave of Corona pandemic, vaccinations and diplomacy

 

There is no way to understand the global trend of second wave of coronavirus from patient identification and death rate in Bangladesh. 

However, the number of infected people in the world has exceeded 90 million and the number of deaths has reached 2 million. 

Two new types in Britain and South Africa are showing signs of speeding up the transmission. Although this trend was evident in Europe and America at the beginning of the winter season, it is now seen that the level of this infection is higher than anywhere else in Asia. 




The most recent addition to this section is the declaration of a state of emergency in Malaysia on 13 December. 

The king there has indicated that the state of emergency could last until August. Japan has also given another new kind of news.

Two figures can be cited here to illustrate how dire the situation is in the Western Hemisphere. Experts in Britain estimate that one in five people are infected with corona. 

The death toll is already hovering at 85,000 and is expected to exceed one million this month. The situation is similar in other European countries.

 There is a widespread misconception that the situation in subcontinent is still relatively tolerable. However, the first shock did not cause any deaths in Bhutan, and the number of infections was limited to a few hundred. 

The number of infections in India as of January 13 was 14 million and the death toll was over 1.5 million.

However, three vaccines have already received emergency approval as a preventative measure and its implementation has begun.

 The World Health Organization (WHO) has said that in order to achieve the maximum benefits of the vaccine in global public health, it must ensure its fair availability. 

The explanation of fair availability is that it should reach those around the world who need it the most, or those who are most at risk. 

Therefore, to ensure its availability everywhere in high and low income countries, its production system and capacity must be increased in such a way that it can reach different ends quickly. 

In reality, of course, that did not happen. Many have increased productivity, but not in a new country. Experts estimate that a total of 200 million doses of the vaccine will be available this year, given the world's current production capacity. 

A total of 100 crore people will be vaccinated this year in two doses per head.

Experts at Imperial College London published an outline of what kind of policy would be most effective in vaccinating against this reality, on September 25 last year.

 Considering the six alternatives, such as the population ratio or the proportion of people over the age of 65, they have calculated the results of vaccine distribution among countries, or how effective it would be if high-income countries were given priority over lower or middle-income countries. 

In their outline, they say that if a country is vaccinated for about 20 percent of the population, it should adopt a strategy to immunize the elderly and most at-risk population.

 Only when supply is high can it be extended to other working populations and children.

Although world leaders do not acknowledge, the competition for vaccines has complicated the situation. 

The main reason for this is the narrowness of selfish nationalism in the competition they have for the priority of the citizens of their respective countries.

But the real situation is much different now. Although world leaders do not acknowledge, the competition for vaccines has complicated the situation. 

The main reason for this is the narrowness of selfish nationalism in the competition they have for the priority of the citizens of their respective countries. 

UN Secretary-General Antonio Guterres, the World Health Organization, UNICEF, the United Nations High Commissioner for Refugees, UNHCR and the world's top health experts have been warning about the vaccine for months, but no one has listened.

Besides, there is not as much interest behind the vaccines invented by the West as in the case of Chinese and Russian vaccines. 

The two countries are not at all keen on the international audit needed to ensure the safety of their vaccines. 

Even then their vaccines are being sent to many third world countries and preparations for delivery are underway. Basically, they are using their invented vaccine as an element of diplomacy. 

The Chinese foreign minister visited several African countries last weekend and reiterated that China would give priority to Africa in providing its vaccines. 

India has also approved the Biotech's covacin and announced that it will be sent as a gift to various countries before the necessary tests to compete with China in vaccination diplomacy.

Pfizer vaccine is one of the three vaccines that are now being used in various countries, including the United Kingdom and the United States. 

But because of the extremely cold temperatures that require transportation and maintenance, its use is limited to a handful of Western countries. 

This is followed by the Oxford-invented AstraZeneca vaccine and the United States' Moderna vaccine. The AstraZeneca vaccine, however, has not yet been approved in the European Union. 

Even in countries where the supply of vaccines is matched, various problems have to be dealt with in the distribution system

In Western countries, including Britain, the elderly have been given the highest priority in vaccination. In the first phase, vaccinations were given to caregivers over the age of 65, elderly residents and caregivers.

Then there are healthcare providers and people over 60 but suffering from other complex diseases. Then the age group of 75+, 70+, 65+, 60+ will get priority in phases.

 There is no separate priority for any professional other than healthcare. The London Police Commissioner wrote an article in the Telegraph that the police should get this benefit because they work on the frontline in dealing with the epidemic.

India have approved the AstraZeneca vaccine. Vaccination in India will start on January 16. 

The Indian government plans to vaccinate 300 million people by next August, which means they will have to vaccinate more than 40 million people every month.

In other South Asian countries, although it was initially said that vaccines would be available first, later it was said that many countries will buy vaccine from India.

 However, according to their government's latest statement, it may be possible in the first week of February. Of course, at twice the price of the European Union. 

It is questionable how much benefit their list of priorities will give. In the case of non-healthcare professionals, priority should be given to age and other critical patients at risk of death rather than occupation. 

Isn't it reasonable to prioritize people at risk over healthy people for protection from infection unless there is effective treatment and adequate vaccination? 

The validity of the decision of some countries to extend the time interval by two months in the case of the second dose is also not unquestionable. 

Whether the effectiveness of the vaccine will remain intact or weakened if the second dose is delayed, has not yet been tested in those countries.

Post a Comment

0 Comments